AN IMMUNOCHEMICAL ANALYSIS OF THE HUMAN NUCLEAR PHOSPHOPROTEIN-P53 - NEW MONOCLONAL-ANTIBODIES AND EPITOPE MAPPING USING RECOMBINANT-P53

被引:583
作者
VOJTESEK, B
BARTEK, J
MIDGLEY, CA
LANE, DP
机构
[1] UNIV DUNDEE, CANC RES CAMPAIGN LABS, DEPT BIOCHEM, DUNDEE DD1 4HN, SCOTLAND
[2] INST HEMATOL & BLOOD TRANSFUS, PRAGUE 10, CZECHOSLOVAKIA
关键词
IMMUNOCHEMICAL ANALYSIS; NUCLEAR PHOSPHOPROTEIN P53; MONOCLONAL ANTIBODY; EPITOPE MAPPING;
D O I
10.1016/0022-1759(92)90122-A
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Somatic mutation of the p53 gene is a very frequent event in the development of human neoplasia, and germ line mutations in p53 are responsible for an inherited cancer susceptibility syndrome. Many of the mutations in p53 found in human tumours are point mutations that result in the substitution of a single amino acid in the protein. These point mutant proteins are much more stable than the normal protein and the mutant product accumulates to a high level which permits important information about p53 expression to be obtained by immunochemical analysis. Using bacterial expression systems to produce fragments of human p53 we have isolated and characterised new monoclonal antibodies to p53. These antibodies are suitable for the measurement of p53 in ELISA, immunoblotting and immunoprecipitation analyses. They are especially useful in immunohistochemistry as they are able to react strongly with p53 in conventionally fixed and processed histological sections.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 24 条
  • [1] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [2] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [3] BARTEK J, 1991, ONCOGENE, V6, P1699
  • [4] BARTEK J, 1990, ONCOGENE, V5, P893
  • [5] BENNETT WP, 1991, ONCOGENE, V6, P1779
  • [6] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [7] GENETIC MECHANISMS OF TUMOR SUPPRESSION BY THE HUMAN P53 GENE
    CHEN, PL
    CHEN, YM
    BOOKSTEIN, R
    LEE, WH
    [J]. SCIENCE, 1990, 250 (4987) : 1576 - 1580
  • [8] THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION
    FINLAY, CA
    HINDS, PW
    LEVINE, AJ
    [J]. CELL, 1989, 57 (07) : 1083 - 1093
  • [9] ACTIVATING MUTATIONS IN P53 PRODUCE A COMMON CONFORMATIONAL EFFECT - A MONOCLONAL-ANTIBODY SPECIFIC FOR THE MUTANT FORM
    GANNON, JV
    GREAVES, R
    IGGO, R
    LANE, DP
    [J]. EMBO JOURNAL, 1990, 9 (05) : 1595 - 1602
  • [10] GUSTERSON BA, 1991, ONCOGENE, V6, P1785